Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Laverty

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Bioorganic & Medicinal Chemistry Letters|October 12, 2010
An in situ oxidation strategy towards overcoming hERG affinityDavid C Pryde, Rhys Jones, Donald S Middleton, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 15, 2018
Acute Tissue Mineral Deposition in Response to a Phosphate Pulse in Experimental CKDJason Ge Zelt, Bruno A Svajger, Kieran Quinn, et al.
Physiological Reports|May 10, 2017
Validation of a routine two-sample iohexol plasma clearance assessment of GFR and an evaluation of common endogenous markers in a rat model of CKDMandy E Turner, Kimberly J Laverty, Paul S Jeronimo, et al.
Biorxiv : the Preprint Server for Biology|February 13, 2023
ATM phosphorylates the FATC domain of DNA-PK <sub>cs</sub> at threonine 4102 to promote non-homologous end joiningHuiming Lu, Qin Zhang, Daniel J Laverty, et al.
Pharmacology Research & Perspectives|June 11, 2020
PTH suppression by calcitriol does not predict off-target actions in experimental CKDBruno A Svajger, Cynthia M Pruss, Kimberly J Laverty, et al.
Neuro-Oncology Advances|June 15, 2026
Pharmacologic inhibition of RBBP4/p300-mediated homologous recombination activity enhances glioblastoma sensitivity to temozolomideJosephine A Mapunda, Daniel J Laverty, Faisal Aziz, et al.
Nucleic Acids Research|June 13, 2023
ATM phosphorylates the FATC domain of DNA-PKcs at threonine 4102 to promote non-homologous end joiningHuiming Lu, Qin Zhang, Daniel J Laverty, et al.
Nature Communications|June 21, 2024
ATM inhibition exploits checkpoint defects and ATM-dependent double strand break repair in TP53-mutant glioblastomaDaniel J Laverty, Shiv K Gupta, Gary A Bradshaw, et al.
Journal of Cellular Biochemistry|November 12, 2025
Bmpr2 Loss in the Vascular Endothelium Enhances Neoangiogenesis and Growth of Lung Metastatic Lesions in a Mouse Model of Breast CancerJordan A Harry, Sofia I Skebo, Devon V Cole, et al.
Progress in Biophysics and Molecular Biology|March 6, 2021
An effective human uracil-DNA glycosylase inhibitor targets the open pre-catalytic active site conformationMy T Nguyen, Davide Moiani, Zamal Ahmed, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry Letters|October 12, 2010
An in situ oxidation strategy towards overcoming hERG affinityDavid C Pryde, Rhys Jones, Donald S Middleton, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 15, 2018
Acute Tissue Mineral Deposition in Response to a Phosphate Pulse in Experimental CKDJason Ge Zelt, Bruno A Svajger, Kieran Quinn, et al.
Physiological Reports|May 10, 2017
Validation of a routine two-sample iohexol plasma clearance assessment of GFR and an evaluation of common endogenous markers in a rat model of CKDMandy E Turner, Kimberly J Laverty, Paul S Jeronimo, et al.
Biorxiv : the Preprint Server for Biology|February 13, 2023
ATM phosphorylates the FATC domain of DNA-PK <sub>cs</sub> at threonine 4102 to promote non-homologous end joiningHuiming Lu, Qin Zhang, Daniel J Laverty, et al.
Pharmacology Research & Perspectives|June 11, 2020
PTH suppression by calcitriol does not predict off-target actions in experimental CKDBruno A Svajger, Cynthia M Pruss, Kimberly J Laverty, et al.
Neuro-Oncology Advances|June 15, 2026
Pharmacologic inhibition of RBBP4/p300-mediated homologous recombination activity enhances glioblastoma sensitivity to temozolomideJosephine A Mapunda, Daniel J Laverty, Faisal Aziz, et al.
Nucleic Acids Research|June 13, 2023
ATM phosphorylates the FATC domain of DNA-PKcs at threonine 4102 to promote non-homologous end joiningHuiming Lu, Qin Zhang, Daniel J Laverty, et al.
Nature Communications|June 21, 2024
ATM inhibition exploits checkpoint defects and ATM-dependent double strand break repair in TP53-mutant glioblastomaDaniel J Laverty, Shiv K Gupta, Gary A Bradshaw, et al.
Journal of Cellular Biochemistry|November 12, 2025
Bmpr2 Loss in the Vascular Endothelium Enhances Neoangiogenesis and Growth of Lung Metastatic Lesions in a Mouse Model of Breast CancerJordan A Harry, Sofia I Skebo, Devon V Cole, et al.
Progress in Biophysics and Molecular Biology|March 6, 2021
An effective human uracil-DNA glycosylase inhibitor targets the open pre-catalytic active site conformationMy T Nguyen, Davide Moiani, Zamal Ahmed, et al.
Pageof 4